Christophe Roberge
Chief Tech/Sci/R&D Officer presso MEDINCELL S.A.
Posizioni attive di Christophe Roberge
Società | Posizione | Inizio | Fine |
---|---|---|---|
MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 01/05/2016 | - |
Storia della carriera di Christophe Roberge
Precedenti posizioni note di Christophe Roberge
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | 01/01/2003 | 01/01/2008 |
Formazione di Christophe Roberge
Institut National de la Recherche Scientifique | Doctorate Degree |
Statistiche
Distribuzione geografica
Canada | 2 |
Francia | 2 |
2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDINCELL S.A. | Health Technology |
Aziende private | 1 |
---|---|
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Christophe Roberge
- Esperienza